12-32399960-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_001370298.3(FGD4):c.166+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.000136 in 1,465,796 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001370298.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGD4 | NM_001370298.3 | c.166+1G>A | splice_donor_variant, intron_variant | Intron 1 of 16 | ENST00000534526.7 | NP_001357227.2 | ||
FGD4 | NM_001384126.1 | c.166+1G>A | splice_donor_variant, intron_variant | Intron 1 of 17 | NP_001371055.1 | |||
FGD4 | XR_001748576.2 | n.402+1G>A | splice_donor_variant, intron_variant | Intron 1 of 8 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000579 AC: 4AN: 69078Hom.: 0 AF XY: 0.0000256 AC XY: 1AN XY: 39064
GnomAD4 exome AF: 0.000133 AC: 175AN: 1313630Hom.: 1 Cov.: 33 AF XY: 0.000126 AC XY: 81AN XY: 642838
GnomAD4 genome AF: 0.000158 AC: 24AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: FGD4 c.-102624G>A is located in the untranscribed region upstream of the FGD4 gene region in transcript NM_139241.3, however it might affect a splice site in other transcripts (c.166+1G>A, in NM_001370298.3). The variant allele was found at a frequency of 0.00016 in 150938 control chromosomes (gnomAD v3.1.2). To our knowledge, no occurrence of c.-102624G>A in individuals affected with Charcot-Marie Disease Type 4H and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at